Sugarman, P., Mitchell, A., Frogley, C., Dickens, G. and Picchioni, M. (2013) Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance. Therapeutic Advances in Psychopharmacology. 3(4), pp. 233-243. 2045-1253.
- Information
Information
Abstract:
The growing worldwide use of pharmaceuticals is managed in some countries by a regulatory system which sharply divides legal use into licensed and unlicensed categories. We examine how for the range of psychotropics this simultaneously restricts the possible benefits to patients, prescribers and producers in some domains, while failing to manage the risks in others. A more flexible system, which shares at an earlier stage experience and evidence on benefits and risks in patients, previously marginalized on the grounds of age, diagnosis or comorbidity, would aid the development of safer, more effective ‘real-world prescribing’. Practical recommendations are made for a new model of research and prescribing governance, to enable more effective repurposing of these treatments.
Uncontrolled Keywords:
Antidepressants, antipsychotics, off-label prescription, off-licence, mental health, pharmacotherapy, psychotropic medication, repurposing
Subjects:
Creators:
Sugarman, P., Mitchell, A., Frogley, C., Dickens, G. and Picchioni, M.
Publisher:
Sage
Northamptonshire and East Midlands:
Health
Faculties, Divisions and Institutes:
Date:
August 2013
Date Type:
Publication
Page Range:
pp. 233-243
Journal or Publication Title:
Therapeutic Advances in Psychopharmacology
Volume:
3
Number:
4
Language:
English
ISSN:
2045-1253
Status:
Published / Disseminated
 |